Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0372 Transporter Info | ||||
Gene Name | SLC46A1 | ||||
Transporter Name | Proton-coupled folate transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Hypermethylation of SLC46A1 in leukemia | [ 1 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes | Down regulation ofSLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Leukemia[ ICD-11:2B33] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
SLC46A1 had increased methylation and decreased expression in pancreatic cancer. | ||||
Mesothelioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Hypermethylation of SLC46A1 in mesothelioma | [ 2 ] | |||
Location |
Promoter (-309 to 104 bp) | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes | Down regulation ofSLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Mesothelioma[ ICD-11:2C26] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
Modulation of promoter methylation by 5-aza-2'-deoxycytidine may eradicate antifolate-resistant tumor cells displaying low SLC46A1 levels. | ||||
Cervical cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Hypomethylation of SLC46A1 in cervical cancer (compare with antifolate-resistant counterpart cells) | [ 3 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes | Down regulation ofSLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Cervical cancer[ ICD-11:2C77.Z] | ||||
Experimental Material |
Human cervical carcinoma cell line (Hela) | ||||
Additional Notes |
Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line. | ||||
Prostate cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
5'UTR (cg13765368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.93E+00 | Statistic Test | p-value:1.40E-02; Z-score:1.17E+01 | ||
Methylation in Case |
3.02E-01 (Median) | Methylation in Control | 7.69E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
TSS1500 (cg23531340) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:3.43E-02; Z-score:1.48E+00 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg26954464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:2.29E-03; Z-score:3.19E+00 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 7.52E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg02349468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.68E+00 | Statistic Test | p-value:3.84E-03; Z-score:-2.94E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 5.99E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg12589308) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:1.12E-02; Z-score:2.54E+00 | ||
Methylation in Case |
9.50E-01 (Median) | Methylation in Control | 9.01E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg11017086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.62E+00 | Statistic Test | p-value:3.96E-02; Z-score:-2.48E+00 | ||
Methylation in Case |
2.41E-01 (Median) | Methylation in Control | 3.91E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
3'UTR (cg15090262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.27E-03; Z-score:3.53E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg27176697) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.67E+00 | Statistic Test | p-value:9.04E-07; Z-score:-6.18E+00 | ||
Methylation in Case |
4.95E-01 (Median) | Methylation in Control | 8.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.49E+00 | Statistic Test | p-value:4.32E-05; Z-score:-3.85E+00 | ||
Methylation in Case |
1.67E-01 (Median) | Methylation in Control | 2.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.38E+00 | Statistic Test | p-value:3.53E-02; Z-score:-1.68E+00 | ||
Methylation in Case |
6.58E-02 (Median) | Methylation in Control | 9.08E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.97E+00 | Statistic Test | p-value:3.30E-02; Z-score:-1.96E+00 | ||
Methylation in Case |
1.35E-02 (Median) | Methylation in Control | 2.67E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:2.37E-02; Z-score:-3.10E+00 | ||
Methylation in Case |
4.64E-01 (Median) | Methylation in Control | 5.59E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:4.65E-02; Z-score:-2.21E-01 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
TSS1500 (cg27176697) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.36E-13; Z-score:1.56E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.38E+00 | Statistic Test | p-value:2.81E-09; Z-score:3.04E+00 | ||
Methylation in Case |
2.86E-01 (Median) | Methylation in Control | 2.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:3.38E-27; Z-score:5.59E+00 | ||
Methylation in Case |
6.33E-01 (Median) | Methylation in Control | 4.06E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.64E+00 | Statistic Test | p-value:7.23E-22; Z-score:4.75E+00 | ||
Methylation in Case |
5.26E-01 (Median) | Methylation in Control | 3.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.44E+00 | Statistic Test | p-value:2.95E-20; Z-score:3.54E+00 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 4.36E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.38E+00 | Statistic Test | p-value:1.10E-12; Z-score:2.43E+00 | ||
Methylation in Case |
6.19E-01 (Median) | Methylation in Control | 4.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:8.75E-09; Z-score:1.19E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 3.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.84E-03; Z-score:-9.68E-01 | ||
Methylation in Case |
7.03E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:1.50E-02; Z-score:7.02E-01 | ||
Methylation in Case |
4.35E-02 (Median) | Methylation in Control | 3.45E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:2.74E-04; Z-score:6.91E-01 | ||
Methylation in Case |
1.60E-02 (Median) | Methylation in Control | 1.47E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:4.10E-03; Z-score:4.79E-01 | ||
Methylation in Case |
2.43E-02 (Median) | Methylation in Control | 2.12E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.55E-02; Z-score:1.29E+00 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 4.92E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:3.56E-02; Z-score:4.28E-01 | ||
Methylation in Case |
2.39E-01 (Median) | Methylation in Control | 2.24E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.70E-02; Z-score:-3.72E-01 | ||
Methylation in Case |
6.41E-02 (Median) | Methylation in Control | 6.84E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:2.64E-02; Z-score:-4.75E-01 | ||
Methylation in Case |
3.44E-02 (Median) | Methylation in Control | 3.91E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg20818262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.74E+00 | Statistic Test | p-value:2.59E-22; Z-score:-5.97E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg17343107) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.65E+00 | Statistic Test | p-value:2.96E-17; Z-score:-3.42E+00 | ||
Methylation in Case |
3.24E-01 (Median) | Methylation in Control | 5.35E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg24585559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:5.53E-13; Z-score:-4.00E+00 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg08535112) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.62E+00 | Statistic Test | p-value:4.05E-10; Z-score:-1.88E+00 | ||
Methylation in Case |
3.96E-01 (Median) | Methylation in Control | 6.43E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg09075844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:1.01E-09; Z-score:-1.80E+00 | ||
Methylation in Case |
3.64E-01 (Median) | Methylation in Control | 4.74E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:1.36E-07; Z-score:-1.25E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 4.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.74E-07; Z-score:-1.41E+00 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 4.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:3.17E-07; Z-score:-1.33E+00 | ||
Methylation in Case |
4.78E-01 (Median) | Methylation in Control | 5.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:5.08E-07; Z-score:-1.52E+00 | ||
Methylation in Case |
4.10E-01 (Median) | Methylation in Control | 4.98E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:1.61E-06; Z-score:-1.02E+00 | ||
Methylation in Case |
3.85E-01 (Median) | Methylation in Control | 4.55E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:7.14E-05; Z-score:1.26E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
3'UTR (cg05749559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:3.82E-14; Z-score:-3.90E+00 | ||
Methylation in Case |
4.41E-01 (Median) | Methylation in Control | 6.33E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:1.47E-04; Z-score:1.21E+00 | ||
Methylation in Case |
3.05E-01 (Median) | Methylation in Control | 2.57E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:4.22E-03; Z-score:1.17E+00 | ||
Methylation in Case |
1.17E-01 (Median) | Methylation in Control | 9.58E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.72E+00 | Statistic Test | p-value:2.32E-03; Z-score:9.52E-01 | ||
Methylation in Case |
1.51E-02 (Median) | Methylation in Control | 8.78E-03 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:3.34E-02; Z-score:9.24E-01 | ||
Methylation in Case |
7.14E-02 (Median) | Methylation in Control | 5.94E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.25E-06; Z-score:-1.21E+00 | ||
Methylation in Case |
8.01E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:6.02E-03; Z-score:3.99E-01 | ||
Methylation in Case |
9.19E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:6.40E-03; Z-score:8.64E-01 | ||
Methylation in Case |
9.36E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:7.16E-03; Z-score:7.82E-01 | ||
Methylation in Case |
8.71E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:2.76E-02; Z-score:1.32E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.89E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:4.30E-02; Z-score:1.14E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 3.25E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:4.76E-02; Z-score:-8.26E-01 | ||
Methylation in Case |
5.02E-02 (Median) | Methylation in Control | 6.01E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.67E-03; Z-score:1.86E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 7.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:5.58E-03; Z-score:1.76E+00 | ||
Methylation in Case |
7.07E-01 (Median) | Methylation in Control | 6.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.42E-02; Z-score:1.49E+00 | ||
Methylation in Case |
7.57E-01 (Median) | Methylation in Control | 6.81E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.00E-02; Z-score:1.68E+00 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg11754206) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.62E-04; Z-score:4.29E-01 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 3.11E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in panic disorder | [ 12 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.33E-01 | Statistic Test | p-value:1.66E-02; Z-score:-5.47E-01 | ||
Methylation in Case |
-4.22E+00 (Median) | Methylation in Control | -3.93E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in panic disorder | [ 12 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:3.04E-02; Z-score:1.56E-01 | ||
Methylation in Case |
3.05E+00 (Median) | Methylation in Control | 2.97E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:4.86E-02; Z-score:-3.12E-01 | ||
Methylation in Case |
7.04E-02 (Median) | Methylation in Control | 7.51E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:4.22E-03; Z-score:6.22E-01 | ||
Methylation in Case |
5.09E-02 (Median) | Methylation in Control | 4.70E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS200 (cg10923085) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:5.17E-03; Z-score:-6.52E-01 | ||
Methylation in Case |
5.33E-02 (Median) | Methylation in Control | 5.90E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:2.57E-02; Z-score:2.84E-01 | ||
Methylation in Case |
8.74E-02 (Median) | Methylation in Control | 8.49E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:2.08E-06; Z-score:1.66E+00 | ||
Methylation in Case |
6.10E-01 (Median) | Methylation in Control | 5.43E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.63E-03; Z-score:-6.57E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:8.12E-03; Z-score:6.67E-01 | ||
Methylation in Case |
5.60E-01 (Median) | Methylation in Control | 5.18E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg21732977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:8.54E-03; Z-score:-6.51E-01 | ||
Methylation in Case |
8.00E-02 (Median) | Methylation in Control | 8.55E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.98E-02; Z-score:9.28E-01 | ||
Methylation in Case |
6.75E-01 (Median) | Methylation in Control | 6.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
TSS200 (cg26763542) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:3.62E-03; Z-score:-1.49E+00 | ||
Methylation in Case |
6.97E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg07601645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:7.08E-05; Z-score:1.53E+00 | ||
Methylation in Case |
6.77E-01 (Median) | Methylation in Control | 6.15E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg13617811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.47E+00 | Statistic Test | p-value:6.64E-04; Z-score:-1.94E+00 | ||
Methylation in Case |
2.56E-01 (Median) | Methylation in Control | 3.76E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg08094571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:2.21E-03; Z-score:-1.67E+00 | ||
Methylation in Case |
3.37E-01 (Median) | Methylation in Control | 3.80E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.81E-03; Z-score:7.33E-01 | ||
Methylation in Case |
9.52E-02 (Median) | Methylation in Control | 8.79E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:4.67E-03; Z-score:9.50E-01 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 9.76E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:3.07E-02; Z-score:1.19E-01 | ||
Methylation in Case |
2.36E-02 (Median) | Methylation in Control | 2.31E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.43E+00 | Statistic Test | p-value:3.25E-10; Z-score:2.61E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 5.01E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:7.22E-07; Z-score:1.63E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 6.06E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:2.70E-05; Z-score:1.44E+00 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 7.61E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.41E-04; Z-score:1.09E+00 | ||
Methylation in Case |
8.37E-01 (Median) | Methylation in Control | 7.56E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:8.52E-04; Z-score:7.71E-01 | ||
Methylation in Case |
7.32E-01 (Median) | Methylation in Control | 6.66E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:7.58E-03; Z-score:6.84E-02 | ||
Methylation in Case |
1.76E-02 (Median) | Methylation in Control | 1.69E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg21732977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.03E-02; Z-score:3.33E-01 | ||
Methylation in Case |
2.98E-02 (Median) | Methylation in Control | 2.58E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:1.82E-02; Z-score:-1.50E-01 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.17E-02; Z-score:-2.21E-01 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.85E+00 | Statistic Test | p-value:2.82E-34; Z-score:-5.11E+00 | ||
Methylation in Case |
4.62E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:2.85E-18; Z-score:-3.87E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 9.54E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg25014117) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:4.28E-16; Z-score:-2.20E+00 | ||
Methylation in Case |
6.22E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:5.20E-04; Z-score:6.30E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.77E-02; Z-score:2.03E-01 | ||
Methylation in Case |
1.36E-01 (Median) | Methylation in Control | 1.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:2.15E-02; Z-score:6.18E-02 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
B-cell acute lymphoblastic leukemia |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-595 downregulates SLC46A1 in B-cell acute lymphoblastic leukemia | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | In-silico analysis | ||
Related Molecular Changes | Down regulation ofSLC46A1 | Experiment Method | Microarrays | ||
miRNA Stemloop ID |
miR-595 | miRNA Mature ID | miR-595 | ||
miRNA Sequence |
GAAGUGUGCCGUGGUGUGUCU | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
B-cell acute lymphoblastic leukemia[ ICD-11:2A82] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SNPs in miR-5189 that might affect SLC46A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL. | ||||
Epigenetic Phenomenon2 |
miR-5189 downregulates SLC46A1 in B-cell acute lymphoblastic leukemia | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | In-silico analysis | ||
miRNA Stemloop ID |
miR-5189 | miRNA Mature ID | miR-5189-5p | ||
miRNA Sequence |
UCUGGGCACAGGCGGAUGGACAGG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
B-cell acute lymphoblastic leukemia[ ICD-11:2A82] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SNPs in miR-5189 that might affect SLC46A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL. | ||||
Unclear Phenotype |
31 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1238 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1238 | miRNA Mature ID | miR-1238-5p | ||
miRNA Sequence |
GUGAGUGGGAGCCCCAGUGUGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon2 |
miR-130a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-130a | miRNA Mature ID | miR-130a-3p | ||
miRNA Sequence |
CAGUGCAAUGUUAAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon3 |
miR-130b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-130b | miRNA Mature ID | miR-130b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUGAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon4 |
miR-138-1 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-138-1 | miRNA Mature ID | miR-138-1-3p | ||
miRNA Sequence |
GCUACUUCACAACACCAGGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-18a directly targets SLC46A1 | [ 21 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-18a | miRNA Mature ID | miR-18a-3p | ||
miRNA Sequence |
ACUGCCCUAAGUGCUCCUUCUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon6 |
miR-1909 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1909 | miRNA Mature ID | miR-1909-5p | ||
miRNA Sequence |
UGAGUGCCGGUGCCUGCCCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon7 |
miR-19a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-19a | miRNA Mature ID | miR-19a-3p | ||
miRNA Sequence |
UGUGCAAAUCUAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon8 |
miR-19b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-19b | miRNA Mature ID | miR-19b-3p | ||
miRNA Sequence |
UGUGCAAAUCCAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon9 |
miR-301a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-301a | miRNA Mature ID | miR-301a-3p | ||
miRNA Sequence |
CAGUGCAAUAGUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon10 |
miR-301b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-301b | miRNA Mature ID | miR-301b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon11 |
miR-3666 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3666 | miRNA Mature ID | miR-3666 | ||
miRNA Sequence |
CAGUGCAAGUGUAGAUGCCGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon12 |
miR-3682 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3682 | miRNA Mature ID | miR-3682-5p | ||
miRNA Sequence |
CUACUUCUACCUGUGUUAUCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon13 |
miR-4295 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4295 | miRNA Mature ID | miR-4295 | ||
miRNA Sequence |
CAGUGCAAUGUUUUCCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon14 |
miR-449b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449b | miRNA Mature ID | miR-449b-3p | ||
miRNA Sequence |
CAGCCACAACUACCCUGCCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon15 |
miR-4511 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4511 | miRNA Mature ID | miR-4511 | ||
miRNA Sequence |
GAAGAACUGUUGCAUUUGCCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon16 |
miR-454 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-454 | miRNA Mature ID | miR-454-3p | ||
miRNA Sequence |
UAGUGCAAUAUUGCUUAUAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon17 |
miR-4658 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4658 | miRNA Mature ID | miR-4658 | ||
miRNA Sequence |
GUGAGUGUGGAUCCUGGAGGAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon18 |
miR-4713 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4713 | miRNA Mature ID | miR-4713-5p | ||
miRNA Sequence |
UUCUCCCACUACCAGGCUCCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon19 |
miR-4758 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4758 | miRNA Mature ID | miR-4758-5p | ||
miRNA Sequence |
GUGAGUGGGAGCCGGUGGGGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon20 |
miR-518a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-518a | miRNA Mature ID | miR-518a-5p | ||
miRNA Sequence |
CUGCAAAGGGAAGCCCUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon21 |
miR-527 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-527 | miRNA Mature ID | miR-527 | ||
miRNA Sequence |
CUGCAAAGGGAAGCCCUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon22 |
miR-561 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-561 | miRNA Mature ID | miR-561-3p | ||
miRNA Sequence |
CAAAGUUUAAGAUCCUUGAAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon23 |
miR-580 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-580 | miRNA Mature ID | miR-580-3p | ||
miRNA Sequence |
UUGAGAAUGAUGAAUCAUUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon24 |
miR-629 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-629 | miRNA Mature ID | miR-629-3p | ||
miRNA Sequence |
GUUCUCCCAACGUAAGCCCAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon25 |
miR-6790 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6790 | miRNA Mature ID | miR-6790-5p | ||
miRNA Sequence |
GUGAGUGUGGAUUUGGCGGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon26 |
miR-6793 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6793 | miRNA Mature ID | miR-6793-3p | ||
miRNA Sequence |
UCCCCAACCCCUGCCCGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon27 |
miR-6814 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6814 | miRNA Mature ID | miR-6814-5p | ||
miRNA Sequence |
UCCCAAGGGUGAGAUGCUGCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon28 |
miR-6844 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6844 | miRNA Mature ID | miR-6844 | ||
miRNA Sequence |
UUCUUUGUUUUUAAUUCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon29 |
miR-6867 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6867 | miRNA Mature ID | miR-6867-3p | ||
miRNA Sequence |
CUCUCCCUCUUUACCCACUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon30 |
miR-6895 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6895 | miRNA Mature ID | miR-6895-5p | ||
miRNA Sequence |
CAGGGCCAGGCACAGAGUAAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon31 |
miR-8081 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-8081 | miRNA Mature ID | miR-8081 | ||
miRNA Sequence |
CUUGAGUCGUGCCUUUCUGAAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.